Your prediction
Pros and Cons of ALS Ltd in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ALS Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ALS Ltd | 0.660% | 6.294% | 9.353% | 55.102% | 22.581% | 87.654% | 143.200% |
| Downer EDI Ltd | 2.000% | 11.842% | 14.350% | 56.442% | 14.865% | 169.841% | 56.442% |
| Seek Ltd | -0.500% | 2.062% | -24.427% | -30.769% | -24.427% | -34.000% | -39.634% |
| Fti Consulting | -0.710% | 2.941% | -7.285% | -11.392% | -4.110% | -18.129% | 45.078% |
News
North American Niobium Highlights 0.150% Nb2O5 with 124.53 ppm Dy2O3 from Pegmatite Grab Sample and 0.19% TREO from REE-Bearing Carbonatite Outcrop at Seigneurie, Québec
Vancouver, British Columbia – February 17, 2026 – North American Niobium and Critical Minerals Corp. (CSE: NIOB) (OTCQB: NIOMF) (FSE: KS82.F) (“North American Niobium” or the “Company”) is
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
- This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo in ALS patients, which is carried to the CNS, where it binds to and damages
RE-Transmission: Vanguard Mining Reports Re-Assay Program for Redonda Copper-Molybdenum Project
Vancouver, BC – January 30, 2026 – Vanguard Mining Corp. ("Vanguard" or the "Company") (CSE: UUU | OTC: UUUFF | FSE: SL51) is pleased to announce that the Company plans to undertake